Gilead Sciences, Inc.
About Gilead
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines for areas of unmet medical need in the United States, Europe, and internationally.
The company focuses on:
-
HIV/AIDS: Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, Atripla (HIV treatment and prevention)
-
Liver Diseases: Epclusa, Harvoni, Vosevi (hepatitis C), Vemlidy, Viread (hepatitis B)
-
COVID-19: Veklury (remdesivir, intravenous antiviral for COVID-19)
-
Oncology & Cell Therapy: Yescarta, Tecartus (CAR T-cell therapies), Trodelvy (triple-negative breast cancer and urothelial cancer), Zydelig (chronic lymphocytic leukemia and follicular lymphoma)
-
Pulmonary & Cardiovascular: Letairis (pulmonary arterial hypertension), Ranexa (chronic angina)
-
Anti-infectives: AmBisome (serious invasive fungal infections)
Collaborations: Gilead has partnership agreements with Arcus Biosciences, Pionyr Immunotherapeutics, Tizona Therapeutics, Tango Therapeutics, Jounce Therapeutics, Galapagos NV, Janssen Sciences, Japan Tobacco, Gadeta B.V., Bristol-Myers Squibb, Dragonfly Therapeutics, and Merck & Co.
Gilead Sciences was incorporated in 1987 and is headquartered in Foster City, California.
Gilead's Business Strategy
Gilead operates with a dual-focus strategy balancing its established leadership in viral diseases (HIV, hepatitis) with a strategic expansion into oncology and inflammatory conditions. The company's business model has evolved from historically developing small molecule antivirals to a broader approach incorporating biologics and cell therapies.
Revenue…
Available on Finplify
Free account required
Our Take on Gilead
Pros:
✅ HIV & Antiviral Therapies Strong Franchise: Gilead is a global leader in HIV treatment, with a highly resilient and recurring revenue stream from its best-in-class therapies like Biktarvy and Descovy. The company’s antiviral expertise also extends to hepatitis C and COVID-related antivirals.
✅ **HIV…
Available on Finplify
Free account required
Company Details
Key Metrics
Fundamental Analysis
Proprietary 5-category scoring system
Score Fingerprint
Section Scores
Full Breakdown & Peer Ranking
See the detailed score for every metric and how this stock ranks against its sector peers
Unlock the full research on Gilead
Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.
300+ Curated Stocks
A hand-picked universe of world-class businesses across every major market and sector.
AI Analyst Briefings
Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.
Proprietary Fundamentals
Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.